Showing results (1791-1800 of 3,518) with videos related to
Sort By:
Pageof 352
Molecular Immunology|April 1, 1992
A sodium channel opener inhibits stimulation of human peripheral blood mononuclear cellsC Pieri, R Recchioni, F Moroni, et al.Blood|March 20, 2004
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesisMarco Rusnati, Maura Camozzi, Emanuela Moroni, et al.Genes & Development|June 1, 1997
Cyclin E-induced S phase without activation of the pRb/E2F pathwayJ Lukas, T Herzinger, K Hansen, et al.ACS Applied Materials & Interfaces|October 19, 2017
Direct Writing Electrospinning of Scaffolds with Multidimensional Fiber Architecture for Hierarchical Tissue EngineeringHonglin Chen, Afonso de Botelho Ferreira Braga Malheiro, Clemens van Blitterswijk, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 21, 2023
Solid-state properties of Nifurtimox. Preparation, analytical characterization, and stability of an amorphous phaseAldana B Moroni, Elena Perez Mayoral, Diego F Lionello, et al.Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|November 15, 1976
[Changes during the six years after an experimental radioactive contamination in man]M Delpla, J P Moroni, P Bournay, et al.Journal of Cellular and Molecular Medicine|October 6, 2016
HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathwayLaura Lucarini, Mariaconcetta Durante, Cecilia Lanzi, et al.Journal of Computer Assisted Tomography|June 10, 2003
Comparison of spirometric-gated and -ungated HRCT in COPDChiara Moroni, Mario Mascalchi, Gianna Camiciottoli, et al.Current Pharmaceutical Design|February 7, 2003
Heparin derivatives as angiogenesis inhibitorsM Presta, D Leali, H Stabile, et al.Minerva Cardioangiologica|July 1, 1994
[Clinical use of echo-dipyridamole test in hypertensive subjects with suspected ischemic heart disease]R Cassone, C Moroni, O Schillaci, et al.Pageof 352